Megan Kelly

410 total citations
12 papers, 305 citations indexed

About

Megan Kelly is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Megan Kelly has authored 12 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Megan Kelly's work include Multiple Myeloma Research and Treatments (6 papers), Retinoids in leukemia and cellular processes (3 papers) and Cancer Treatment and Pharmacology (3 papers). Megan Kelly is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Retinoids in leukemia and cellular processes (3 papers) and Cancer Treatment and Pharmacology (3 papers). Megan Kelly collaborates with scholars based in United States, Egypt and Canada. Megan Kelly's co-authors include Rachid Baz, Mohamad A. Hussein, Mary Ann Karam, Janice Reed, Esteban Walker, Steven Andrèsen, Andrew Fagan, Jasmohan S. Bajaj, Hugo E. Vargas and Leroy R. Thacker and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Mayo Clinic Proceedings.

In The Last Decade

Megan Kelly

12 papers receiving 303 citations

Peers

Countries citing papers authored by Megan Kelly

Since Specialization

Citations

This map shows the geographic impact of Megan Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Kelly more than expected).

Fields of papers citing papers by Megan Kelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Kelly. The network helps show where Megan Kelly may publish in the future.

Co-authorship network of co-authors of Megan Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Megan Kelly. A scholar is included among the top collaborators of Megan Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan Kelly. Megan Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Minimal Hepatic Encephalopathy and Mild Cognitive Impairment Worsen Quality of Life in Elderly Patients With Cirrhosis 2020 ·Clinical Gastroenterology and Hepatology ·Jasmohan S. Bajaj, Andrés Duarte‐Rojo, Jesse J. Xie, Chathur Acharya, James B. Wade, (unknown), Leroy R. Thacker, (unknown), Andrew Fagan, Mauricio García-Saenz-de-Sicilia, Melanie B. White, Megan Kelly, Vy H. Nguyen, Edith Gavis, Hugo E. Vargas	52
2	Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis 2018 ·Clinical Gastroenterology and Hepatology ·Jasmohan S. Bajaj, Hugo E. Vargas, K. Rajender Reddy, Jennifer C. Lai, Jacqueline G. O’Leary, Puneeta Tandon, Florence Wong, Robert Mitrani, Melanie B. White, Megan Kelly, Andrew Fagan, (unknown), (unknown), Masoumeh Sikaroodi, Leroy R. Thacker, Patrick M. Gillevet	90
3	Hyper-CVAD plus nelarabine in the treatment of newly diagnosed patients with T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (T-ALL/LL). 2011 ·Journal of Clinical Oncology ·(unknown), (unknown), Farhad Ravandi, Susan O’Brien, H. Kantarjian, Gautam Borthakur, Tapan M. Kadia, Megan Kelly, Rebecca Garris, S. Faderl	1
4	Prediction of Response and Progression in Multiple Myeloma With Serum Free Light Chains Assay: Corroboration of the Serum Free Light Chain Response Definitions 2010 ·Clinical Lymphoma Myeloma & Leukemia ·Rami Khoriaty, Mohamad A. Hussein, Beth Faiman, Megan Kelly, Matt Kalaycio, Rachid Baz	5
5	Combination of rituximab and oral melphalan and prednisone in newly diagnosed multiple myeloma 2007 ·Leukemia & lymphoma ·Rachid Baz, Suzanne Fanning, Lori Kunkel, Sameh Gaballa, Mary Ann Karam, Janice Reed, Megan Kelly, Mohamad A. Hussein	11
6	An association between renal cell carcinoma and multiple myeloma: a case series and clinical implications 2007 ·British Journal of Urology ·Toni K. Choueiri, Rachid Baz, (unknown), Mohamad Khasawneh, Mary Ann Karam, Megan Kelly, Mohamad A. Hussein	19
7	Phase 2 Study of Pegylated Liposomal Doxorubicin, Vincristine, Decreased-Frequency Dexamethasone, and Thalidomide in Newly Diagnosed and Relapsed-Refractory Multiple Myeloma 2006 ·Mayo Clinic Proceedings ·Mohamad A. Hussein, Rachid Baz, Gordan Srkalović, (unknown), (unknown), Eric D. Hsi, Steven Andrèsen, Mary Ann Karam, Janice Reed, Beth Faiman, Megan Kelly, Esteban Walker	84
8	Efficacy and Safety Results with the Combination Therapy of Arsenic Trioxide, Dexamethasone, and Ascorbic Acid in Multiple Myeloma Patients: A Phase 2 Trial 2006 ·Medical Oncology ·Rony M. Abou-Jawde, Janice Reed, Megan Kelly, Esteban Walker, Steven Andrèsen, Rachid Baz, Mary Ann Karam, Mohamad A. Hussein	33
9	Phase II study of dexamethasone, ascorbic acid, thalidomide and arsenic trioxide (DATA) in high risk previously untreated (PU) and relapsed/refractory (RR) multiple myeloma (MM) 2006 ·Journal of Clinical Oncology ·Rachid Baz, Megan Kelly, Janice Reed, Mary Ann Karam, Beth Faiman, S Andresen, M. A. Hussein	3
10	Aggressive Electrolytes Replacement in Multiple Myeloma (MM) Patients Receiving Arsenic Trioxide (ATO) Containing Regimens Alleviates the Need for Frequent Electrocardiogram (ECG) Monitoring. 2005 ·Blood ·Toni K. Choueiri, Esteban Walker, Rachid Baz, Rony M. Abou-Jawde, Snehal G. Thakkar, (unknown), Megan Kelly, Steven Andrèsen, Mohamad A. Hussein	2
11	Full Dose Vincristine (V) Negatively Impacts Progression Free Survival in Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients Treated with Pegylated Doxorubicin, Vincristine, Reduced-Dose Dexamethasone, and Thalidomide (DVd-T). 2005 ·Blood ·(unknown), Esteban Walker, Khaldoun Almhanna, Steve Andresen, Janice Reed, Mary Ann Karam, (unknown), Megan Kelly, (unknown), (unknown), M. A. Hussein	1
12	Arsenic Trioxide (Trisenox® ATO), Ascorbic Acid (AA) and Dexamethasone (Dex) Pulses (TAD) for Relapsed Refractory Progressive Multiple Myeloma (MM) Patients (pts); a Final Report. 2004 ·Blood ·Rony M. Abou-Jawde, Janice Reed, Megan Kelly, (unknown), Mary Ann Karam, (unknown), Gordan Srkalović, Mohamad A. Hussein	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact